论文部分内容阅读
目的:通过对比观察晚期肺癌患者在接受参麦注射液合放射性碘-125粒子植入治疗后的临床效果,探讨参麦注射液合放射性碘-125粒子植入治疗晚期肺癌的临床价值。方法:选取自2012年1月至2014年1月在我院肿瘤外科住院治疗的晚期肺癌患者60例,均采取放射性碘-125粒子植入治疗,同时每日滴注参麦注射液,治疗一个月后,比较患者治疗前后的生活质量、体重和肿瘤体积大小的变化。结果:所有患者治疗后的生活质量评分和体重均比治疗前有所上升,差异有统计学意义(P<0.05);患者治疗后的肿瘤体积均比治疗前明显缩小,差异有统计学意义(P<0.05)。结论:对于临床上晚期肺癌患者,为最大程度的减少患者的疼痛和提高生活质量,采取参麦注射液合放射性碘-125粒子植入治疗有明显的临床效果,值得在临床上推广应用。
OBJECTIVE: To compare the clinical effects of Shenmai injection with radioactive iodine-125 particle implantation in patients with advanced lung cancer and explore the clinical value of Shenmai injection combined with radioactive iodine-125 particle implantation in the treatment of advanced lung cancer. Methods: Sixty patients with advanced lung cancer hospitalized in our hospital from January 2012 to January 2014 were enrolled in this study. All of them were treated with radioactive iodine-125 particle implantation. At the same time, Shenmai injection One month later, the quality of life, weight and volume of tumor before and after treatment were compared. Results: The quality of life score and body weight of all patients after treatment were higher than those before treatment, the difference was statistically significant (P <0.05). The volume of tumor after treatment in all patients was significantly smaller than that before treatment (the difference was statistically significant P <0.05). Conclusion: For clinical patients with advanced lung cancer, in order to minimize the patient’s pain and improve the quality of life, taking Shenmai injection combined with radioactive iodine-125 particle implantation has obvious clinical effect, which is worth popularizing in clinic.